Arvind Ravi

oncology, genomics, AI | views are my own

[Arvind Ravi @aravi1]

(tagging @Alex_Azizi_ here!)

[Arvind Ravi @aravi1]

Wonderful group meeting presentation by our incredibly talented visiting fellow, Alex Azizi. (Amazing progress over just a few months!) @getz_lab @JustinGainor

[Arvind Ravi @aravi1]

Wonderful group meeting presentation by our incredibly talented visiting fellow, Alex Azizi. (Amazing progress over just a few months!) @getz_lab @JustinGainor

[Gad Getz Laboratory @getz_lab]

(1/2) In @NatureGenet today, check out @aravi1’s work in our #collab with @JustinGainor and the Hacohen lab on #LungCancer #NSCLC factors and predictors of checkpoint blockade response! @broadinstitute @MGHCancerCenter https://t.co/v9AFlnXD5x

[Gad Getz Laboratory @getz_lab]

(1/2) Excited to share our initial findings on genomic and transcriptomic predictors of immunotherapy response in #LungCancer #NSCLC from the first joint analysis of the @SU2C–@TheMarkFdn checkpoint blockade response cohort in our new @biorxiv preprint! https://t.co/eaNHJiKBHI

[Justin Gainor @JustinGainor]

Special thanks to all patients/families and entire EXTOL team, incl Arvind Ravi, Matt Hellmann, K Schalper, P Janni, Alice Shaw @NIVokes @FordePatrick @ValsamoA @n8pennell @VamsiVelcheti @DrRoyHerbstYale @JulieBrahmer @DrMarkAwad @wolchokj @gaddyg @getz_lab @AACR @AmericanCancer

[Arvind Ravi @aravi1]

An important practical step in precision medicine...still an open question of which additional -omics will best power version 2.0

[Nature Portfolio @NaturePortfolio]

Some patients with cancer could benefit from ‘off-label’ drugs that are not routinely prescribed for their specific tumour type, according to a Nature paper. The study is part of the Drug Rediscovery Protocol. https://t.co/30Vj7HjUdI

[Arvind Ravi @aravi1]

Honored to receive a 2019 @ASCO #YIA award for #bladdercancer supported by @ConquerCancerFd. Many thanks to my team of mentors for all of their guidance @gaddyg @eric_lander @broadinstitute @sonpavde @DanaFarber @harvardmed

[Arvind Ravi @aravi1]

A valuable case study in how "opening the black box" can improve collaboration between algorithms and people...

Can an Algorithm Tell When Kids Are in Danger? https://t.co/XmypnNEi2R

[Arvind Ravi @aravi1]

'Driverless' van spotted in Va. had man inside dressed as seat https://t.co/au4g0h7FXr

[Arvind Ravi @aravi1]

A fitting reminder that residency has come to an end...

[Arvind Ravi @aravi1]

Better data analytics should drive who we decide to screen... https://t.co/KlIva3Bt8C

[JAMA @JAMA_current]

Risk-based CT #lungcancer screening assoc'd w greater number of lung cancer deaths prevented over 5 yrs https://t.co/WIT0qp0XSp #ATS2016

[Arvind Ravi @aravi1]

One simple example of how our traditional disease paradigms need a data driven update... https://t.co/v84YkDczuO

[JAMA @JAMA_current]

#Ovariancancer is not one disease but rather has distinct subtypes https://t.co/bGpW4zbviN

[Arvind Ravi @aravi1]

Another early example of >human performance by ML... https://t.co/GhCfyhErqz

[Nature Portfolio @NaturePortfolio]

Learning from failure. Machine-learning algorithm mines unreported ‘dark’ reactions to predict successful syntheses

[Arvind Ravi @aravi1]

Important perspective for those on the leading edge... https://t.co/VGbvTZZVit

[NEJM @NEJM]

Shooting for the moon in cancer science is important, but so is shooting for a world that is just and equitable. https://t.co/gWT8CZrsMo

[Arvind Ravi @aravi1]

Baby steps for the next frontier...
https://t.co/sKGF0G5DVX

[Arvind Ravi @aravi1]

Expect more like this:
Startup Uses Deep Learning to Detect Disease from Medical Scans https://t.co/qBgXeM3n7L via @sharethis

[Arvind Ravi @aravi1]

From Go to Healthcare...
New Study Seeks to Use Deep Learning to Detect Heart Disease https://t.co/HvWGU6jqJY via @WSJ

[Arvind Ravi @aravi1]

Admirable first steps, look forward to more:
8 apps revolutionizing maternal health care in developing natiions
https://t.co/psKnXQu8Mq

[The New York Times @nytimes]

If you think starting a social network business is hard, try selling lemonade https://t.co/H9ZJJ3r9yw

[Eric Topol @EricTopol]

Not advocating whole genome sequencing, but the new price point of < $1K in context of other med stuff is notable